Ganciclovir
Product Images NDC 14335-030

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 14335-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structures (Image 01)

Chemical structures of ganciclovir sodium and ganciclovir, showing their molecular formulas and molecular weights. The image presents the molecular structures with labeled atoms and functional groups for both compounds.*

FDA Label Image

Figure 1 (Image 02)

A line graph titled 'ICM 1653: Time to Progression of CMV Retinitis' showing the proportion without progression over time in days from the start of maintenance therapy. It compares two lines representing IV and oral administration routes, with the y-axis labeled as proportion without progression and the x-axis showing time in days up to 150.*

FDA Label Image

Figure 2 (Image 03)

A line graph titled 'ICM 1774: Time to Progression of CMV Retinitis' showing the proportion without progression over days from the start of maintenance therapy. The graph compares two lines labeled 'IV' (dashed) and 'Oral' (solid), indicating changes in progression rates over approximately 120 days.*

FDA Label Image

Figure 3 (Image 04)

A line graph titled 'AVI 034: Time to Progression of CMV Retinitis,' showing proportion without progression over time from the start of maintenance therapy in days. The y-axis represents the proportion without progression, decreasing from 1 to 0. The x-axis shows time up to 150 days. Two treatment groups are compared: IV (dashed line) and Oral (solid line), depicting the decline in progression-free proportion over time for each.*

FDA Label Image

Principal Display Panel (Vial Label)

Label for Ganciclovir for Injection, USP, 500 mg per vial, by Hainan Poly Pharm. Co., Ltd. The label indicates it is for intravenous infusion only and includes cautionary handling instructions. It states the product is a potent cytotoxic agent and suspected carcinogen. Preparation instructions for solution and storage conditions are provided. The label also shows the NDC 14335-030-01 and the Rx Only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.